Explore 3 Stock Ideas & Industry Insights Download Free Report

Stocks

CrowdStrike CEO Kurtz said ’not riding off into sunset’, remains large shareholder

CrowdStrike (NASDAQ:CRWD) CEO George Kurtz said reports that he sold virtually all of his stock are “false.” Kurtz highlights that he moved stock into trusts for his family as well as causes he supports. He said he remains one of the largest individual shareholders. …

EODHD | 16 May 2025

Microsoft (MSFT) Cuts 6,000 Jobs as Part of Management Restructuring

Microsoft (MSFT, Financials) is letting go of about 6,000 employees across divisions and regionsroughly 3% of its staffas it trims layers of management and resets for growth. Warning! GuruFocus has detected 4 Warning Sign with MSFT. The company confirmed the cuts Tuesday, including 1,985 …

EODHD | 16 May 2025

RRR Q1 Earnings Call: Durango Ramp and Capital Returns Shape Outlook

Casino resort and entertainment company Red Rock Resorts (NASDAQ:RRR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 1.8% year on year to $497.9 million. Its non-GAAP profit of $0.51 per share was 12.9% above analysts’ consensus estimates. Is now the time …

EODHD | 16 May 2025

Take-Two (NASDAQ:TTWO) Posts Better-Than-Expected Sales In Q1 But Full-Year Sales Guidance Misses Expectations Significantly

Video game publisher Take Two (NASDAQ:TTWO) reported Q1 CY2025 results beating Wall Street’s revenue expectations , with sales up 13.1% year on year to $1.58 billion. The company expects next quarter’s revenue to be around $1.38 billion, coming in 4.7% above analysts’ estimates. Its …

EODHD | 16 May 2025

How major US stock indexes fared Thursday, 5/15/2025

Most U.S. stocks drifted higher following a mixed set of reports on the U.S. economy. The S&P 500 rose 0.4% Thursday, enough to extend its winning streak to a fourth day and to pull within 3.7% of its record. The Dow Jones Industrial Average …

EODHD | 16 May 2025

SCYNEXIS Reports First Quarter 2025 Financial Results and Provides Corporate Update

Ibrexafungerp clinical hold lifted by the FDA. SCYNEXIS working to resolve a disagreement with GSK involving the restart of the MARIO study. GSK remains committed to the commercialization of Brexafemme. Hansoh recently received Chinese (NMPA) approval for ibrexafungerp in the treatment of acute VVC. …

EODHD | 16 May 2025

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update

Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its new marketing and distribution model Management to Host Conference Call today at 5:00 pm ET LITTLETON, …

EODHD | 16 May 2025

Cava beats quarterly revenue estimates on strong demand

(Reuters) -Cava Group beat estimates for first-quarter revenue on Thursday, helped by robust demand for its Mediterranean cuisine despite a broader slowdown in dining out across the United States. Cava also maintained its annual forecasts for same-store sales growth and margin at a time …

EODHD | 16 May 2025

SEC investigates Coinbase over accuracy of reported user numbers

On Thursday, Coinbase Global (COIN) confirmed reports that US Securities and Exchange Commission (SEC) officials have been investigating the cryptocurrency exchange over its user metrics. Simultaneously, hackers were found to be bribing non-US Coinbase employees to gain access to customer data; Coinbase is refusing …

EODHD | 16 May 2025

P3 Health Partners Announces First Quarter 2025 Results

Affirming 2025 guidance Management to Host Conference Call and Webcast May 15, 2025 at 4:30 PM ET HENDERSON, Nev., May 15, 2025--(BUSINESS WIRE)--P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its financial …

EODHD | 16 May 2025